Literature DB >> 2117219

Evaluation of alveolitis by studies of lung biopsies.

P L Haslam1.   

Abstract

Immunocytochemical studies of lung biopsies from patients with cryptogenic fibrosing alveolitis and those having fibrosing alveolitis associated with scleroderma show that numerous T-cells occur in the alveolar walls and septa of all patients with these diseases, implying that cell-mediated hypersensitivity reactions are involved in the pathogenesis. However, B-lymphocytes, mainly within lymphoid follicles, are also present and, in the CFA group, such patients, and those with less than 50% T-suppressor/cytotoxic cells in the diffuse T-cell infiltrates, may have a poorer prognosis. Interleukin-2 receptor expression indicates that T-cell activation is occurring within the lungs, and there is evidence that interstitial monocytes/macrophages and alveolar epithelial cells may play a more important role in antigen presentation than alveolar macrophages. These observations on the features of the inflammatory response in the interstitial tissues of patients with fibrosing alveolitis need to be incorporated into the existing hypothesis on pathogenetic mechanisms based mainly on lavage findings of alveolar macrophages and granulocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117219     DOI: 10.1007/bf02718236

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  21 in total

Review 1.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

2.  Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.

Authors:  C G Kallenberg; B M Schilizzi; F Beaumont; S Poppema; L De Leij; T H The
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Usual interstitial pneumonitis is a T-cell alveolitis.

Authors:  R L Kradin; M B Divertie; R B Colvin; J Ramirez; J Ryu; H A Carpenter; A K Bhan
Journal:  Clin Immunol Immunopathol       Date:  1986-08

4.  Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.

Authors:  D A Campbell; L W Poulter; G Janossy; R M du Bois
Journal:  Thorax       Date:  1985-06       Impact factor: 9.139

5.  The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats.

Authors:  R S Thrall; S H Phan; J R McCormick; P A Ward
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

6.  Eosinophil- and eosinophil granule-mediated pneumocyte injury.

Authors:  G H Ayars; L C Altman; G J Gleich; D A Loegering; C B Baker
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

7.  Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

Authors:  A Venet; A J Hance; C Saltini; B W Robinson; R G Crystal
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Effect of the beige mutation on bleomycin-induced pulmonary fibrosis in mice.

Authors:  S H Phan; D Schrier; B McGarry; R E Duque
Journal:  Am Rev Respir Dis       Date:  1983-04

9.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

Authors:  S I Rennard; G W Hunninghake; P B Bitterman; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Role of fibronectin as a growth factor for fibroblasts.

Authors:  P B Bitterman; S I Rennard; S Adelberg; R G Crystal
Journal:  J Cell Biol       Date:  1983-12       Impact factor: 10.539

View more
  9 in total

1.  Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.

Authors:  M Binks; J R Passweg; D Furst; P McSweeney; K Sullivan; C Besenthal; J Finke; H H Peter; J van Laar; F C Breedveld; W E Fibbe; D Farge; E Gluckman; F Locatelli; A Martini; F van den Hoogen; L van de Putte; A V Schattenberg; R Arnold; P A Bacon; P Emery; I Espigado; B Hertenstein; F Hiepe; A Kashyap; I Kötter; A Marmont; A Martinez; M J Pascual; A Gratwohl; H G Prentice; C Black; A Tyndall
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; R Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; T H Tötterman
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

4.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

5.  Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; S N Roberts; H Caldwell; E Thornton; A P Greening; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

6.  A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA).

Authors:  W A Wallace; E A Ramage; D Lamb; S E Howie
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

Review 7.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.

Authors:  M N Sheppard; N K Harrison
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

8.  CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis.

Authors:  Zoe Daniil; Panagiota Kitsanta; George Kapotsis; Maria Mathioudaki; Androniki Kollintza; Marilena Karatza; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  Respir Res       Date:  2005-07-24

Review 9.  Diffuse lung disease: combined clinical and laboratory studies.

Authors:  R M du Bois
Journal:  J R Coll Physicians Lond       Date:  1994 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.